gemcitabine 10 MG/ML [Infugem]
RxNorm concept 2058860, branded drug component (sbdc).
- RxCUI
- 2058860
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2058860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- 120 ML gemcitabine 10 MG/ML Injection [Infugem] (SBD, constitutes)
- 140 ML gemcitabine 10 MG/ML Injection [Infugem] (SBD, constitutes)
- 150 ML gemcitabine 10 MG/ML Injection [Infugem] (SBD, constitutes)
- 160 ML gemcitabine 10 MG/ML Injection [Infugem] (SBD, constitutes)
- 170 ML gemcitabine 10 MG/ML Injection [Infugem] (SBD, constitutes)
- 180 ML gemcitabine 10 MG/ML Injection [Infugem] (SBD, constitutes)
- 190 ML gemcitabine 10 MG/ML Injection [Infugem] (SBD, constitutes)
- 130 ML gemcitabine 10 MG/ML Injection [Infugem] (SBD, constitutes)
- 200 ML gemcitabine 10 MG/ML Injection [Infugem] (SBD, constitutes)
- 220 ML gemcitabine 10 MG/ML Injection [Infugem] (SBD, constitutes)
- Infugem (BN, has ingredient)
- gemcitabine 10 MG/ML (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2058860 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2058860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2058860. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.